Dosage and administration
Adults and children 2 years and older: apply externally to the affected area up to 3-4 times a day. Children under 2 years of age: consult a doctor
Adults and children 2 years and older: apply externally to the affected area up to 3-4 times a day. Children under 2 years of age: consult a doctor
Store at USP controlled room temperature 20-25 o C (68-77 o F).
Lidocaine 4% w/w
Topical Anesthetic
Uses temporarily relieves pain and itching due to:
For external use only
if swallowed, get medical help or contact a Poison Control Center right away
benzyl alcohol, cabomer 940, cholesterol, hydrogenated lecithin, polysorbate 80, propylene glycol, tocopheryl acetate, trolamine, water
40 milligrams/gram per application
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73715-001-01 | Lidocaine 4% Topical Anesthetic Cream | 30 g in 1 TUBE | CREAM | 30 | 5 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 73715-001-01 | GM - Gram | 73715-001 | 4aa19057-e2f5-4ce7-a85a-5a297eac297e | 1 | 2024-04-05 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 73715-001 | 73715-001-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| LIDOCAINE | 98PI200987 | ACTIB |
| WATER | 059QF0KO0R | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 3a5f9898-0e6b-0b66-e063-6394a90a04b9 | a70863f0-48c1-5e6f-e053-2995a90a9606 | 2025-07-20 | Warnings | 3a5f9898-0e6b-0b66-e063-6394a90a04b9 a70863f0-48c1-5e6f-e053-2995a90a9606 |
Adverse event summaries are temporarily unavailable. Other product information remains available.